<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="does not comply with these terms. Abstract Severe fever with" exact="thrombocytopenia" post="syndrome (SFTS) is an emerging tick-borne infectious disease caused"/>
 <result pre="Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne" exact="infectious disease" post="caused by SFTS virus (SFTSV), which is a novel"/>
 <result pre="recent advances in antiviral drugs against SFTSV. severe fever with" exact="thrombocytopenia" post="syndrome severe fever with thrombocytopenia syndrome virus antiviral ribavirin"/>
 <result pre="against SFTSV. severe fever with thrombocytopenia syndrome severe fever with" exact="thrombocytopenia" post="syndrome virus antiviral ribavirin favipiravir Funding Ministry of Health,"/>
 <result pre="fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction Severe fever with" exact="thrombocytopenia" post="syndrome (SFTS) is an emerging tick-borne infectious disease caused"/>
 <result pre="Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne" exact="infectious disease" post="caused by SFTS virus (SFTSV), a novel bunyavirus classified"/>
 <result pre="immunodeficiency virus, Lassa virus, and [in combination with interferon (IFN)-α]" exact="hepatitis" post="C virus. Ribavirin can be administered orally, intravenously, or"/>
 <result pre="broad spectrum of activity against various RNA viruses, including the" exact="influenza" post="virus, arenaviruses, bunyaviruses, West Nile virus, yellow fever virus,"/>
 <result pre="viruses, including the influenza virus, arenaviruses, bunyaviruses, West Nile virus," exact="yellow fever" post="virus, and foot-and-mouth disease virus (Furuta et al., 2009)."/>
 <result pre="of thrombopoietin receptor (c-Mpl) for the treatment of immune thrombocytopenic" exact="purpura" post="and aplastic anemia (eltrombopag), and an antiprotozoal agent (broxyquinoline)."/>
 <result pre="receptor (c-Mpl) for the treatment of immune thrombocytopenic purpura and" exact="aplastic anemia" post="(eltrombopag), and an antiprotozoal agent (broxyquinoline). Of them, hexachlorophene"/>
 <result pre="(c-Mpl) for the treatment of immune thrombocytopenic purpura and aplastic" exact="anemia" post="(eltrombopag), and an antiprotozoal agent (broxyquinoline). Of them, hexachlorophene"/>
 <result pre="2013), West Nile virus (Scherbik and Brinton, 2010), and Japanese" exact="encephalitis" post="virus (Wang et al., 2017) has been reported. Screening"/>
 <result pre="of the most widely used drugs for treating hypertension and" exact="atherosclerosis" post="in China. Thus, Li et al. (2019) performed a"/>
 <result pre="al., 2016), Crimean-Congo hemorrhagic fever virus (Welch et al., 2017)," exact="influenza" post="virus (Kumaki et al., 2011), and herpesviruses (Wohlrab et"/>
 <result pre="1999). It exerts a variety of biological effects, including the" exact="suppression" post="of cancer cells (Tang et al., 2017; Bułdak et"/>
 <result pre="exerts a variety of biological effects, including the suppression of" exact="cancer" post="cells (Tang et al., 2017; Bułdak et al., 2018)"/>
 <result pre="al., 2017). The mechanism of inhibitory activity of amodiaquine against" exact="malaria" post="and those viruses remains unclear. Baba et al. (2017)"/>
 <result pre="of the possible adverse events induced by ribavirin such as" exact="anemia" post="and hyperamylasemia (Lu et al., 2015). Favipiravir exhibited higher"/>
 <result pre="diseases caused by ebola virus (Mendoza et al., 2017) and" exact="influenza" post="(Nachbagauer and Krammer, 2017). Antibody drugs neutralize viruses or"/>
 <result pre="et al., 2019; Kwak et al., 2019). A recombinant vesicular" exact="stomatitis" post="virus expressing SFTSV antigen completely protected mice from SFTSV"/>
 <result pre="an antiviral assay system and identification of severe fever with" exact="thrombocytopenia" post="syndrome virus inhibitors. Antivir. Chem. Chemother.25, 83–89. 10.1177/204020661774030329096526 BajramovicJ."/>
 <result pre="its selected bioactive compounds on the development and progression of" exact="colorectal cancer" post="in vivo and in vitro. Molecules23:E3309. 10.3390/molecules2312330930551667 ChenX. P.CongM."/>
 <result pre="selected bioactive compounds on the development and progression of colorectal" exact="cancer" post="in vivo and in vitro. Molecules23:E3309. 10.3390/molecules2312330930551667 ChenX. P.CongM."/>
 <result pre="W.BaeI. G.KimS. H.RyuS. Y.KimH. A.et al.. (2016). Severe fever with" exact="thrombocytopenia" post="syndrome in South Korea, 2013-2015. PLoS Negl. Trop. Dis.10:e0005264."/>
 <result pre="Rev.29, 695–747. 10.1128/CMR.00102-1527281742 DelangL.GuerreroN. S.TasA.QuératG.PastorinoB.FroeyenM.et al.. (2014). Mutations in the" exact="chikungunya" post="virus non-structural proteins cause resistance to favipiravir (T-705), a"/>
 <result pre="channel blocker bepridil demonstrates efficacy in the murine model of" exact="marburg virus disease." post="J. Infect. Dis.22, S588–S591. 10.1093/infdis/jiy332 DingY.CaoZ.CaoL.DingG.WangZ.XiaoW. (2017). Antiviral activity"/>
 <result pre="S588–S591. 10.1093/infdis/jiy332 DingY.CaoZ.CaoL.DingG.WangZ.XiaoW. (2017). Antiviral activity of chlorogenic acid against" exact="influenza" post="A (H1N1/H3N2) virus and its inhibition of neuraminidase. Sci."/>
 <result pre="a rVSV-based vaccine elicits complete protection against severe fever with" exact="thrombocytopenia" post="syndrome virus. NPJ Vaccines4:5. 10.1038/s41541-018-0096-y30701094 FerrariG.HaynesB. F.KoenigS.NordstromJ. L.MargolisD. M.TomarasG."/>
 <result pre="GaiZ.LiangM.ZhangY.ZhangS.JinC.WangS. W.et al.. (2012). Person-to-person transmission of severe fever with" exact="thrombocytopenia" post="syndrome bunyavirus through blood contact. Clin. Infect. Dis.54, 249–252."/>
 <result pre="WettereA. J.RigasJ. D.HickersonB. T.et al.. (2017). Modeling severe fever with" exact="thrombocytopenia" post="syndrome virus infection in golden syrian hamsters: importance of"/>
 <result pre="10.1093/infdis/jiu56425326554 JinC.LiangM.NingJ.GuW.JiangH.WuW.et al.. (2012). Pathogenesis of emerging severe fever with" exact="thrombocytopenia" post="syndrome virus in C57/BL6 mouse model. Proc. Natl. Acad."/>
 <result pre="al.. (2016). Epidemiological and clinical features of severe fever with" exact="thrombocytopenia" post="syndrome in Japan, 2013-2014. PLoS ONE11:e0165207. 10.1371/journal.pone.016520727776187 KidaK.MatsuokaY.ShimodaT.MatsuokaH.YamadaH.SaitoT.et al.."/>
 <result pre="(2019). A case of cat-to-human transmission of severe fever with" exact="thrombocytopenia" post="syndrome virus. Jpn. J. Infect. Dis.72, 356–358. 10.7883/yoken.JJID.2018.52631366857 KimK."/>
 <result pre="convalescent patient potently inhibits the infection of severe fever with" exact="thrombocytopenia" post="syndrome virus. PLoS Pathog.15:e1007375. 10.1371/journal.ppat.100737530707748 KimK. H.YiJ.KimG.ChoiS. J.JunK. I.KimN."/>
 <result pre="KimK. H.YiJ.KimG.ChoiS. J.JunK. I.KimN. H.et al.. (2013). Severe fever with" exact="thrombocytopenia" post="syndrome, South Korea, 2012. Emerg. Infect. Dis.19, 1892–189410.3201/eid1911.13079224206586 KimbroughR."/>
 <result pre="and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic" exact="avian influenza" post="H5N1, seasonal, and pandemic H1N1 virus infections. Antiviral Res.92,"/>
 <result pre="in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian" exact="influenza" post="H5N1, seasonal, and pandemic H1N1 virus infections. Antiviral Res.92,"/>
 <result pre="of metal chelates of caffeic acid and similar compounds towards" exact="herpes simplex," post="VSV-Ebola pseudotyped and vaccinia viruses. Antiviral Res.160, 143–150. 10.1016/j.antiviral.2018.10.02130393014"/>
 <result pre="In vitro antiviral activity of ribavirin against severe fever with" exact="thrombocytopenia" post="syndrome virus. Korean J. Intern. Med.32, 731–737. 10.3904/kjim.2016.10927899013 LiH.LuQ.BinX."/>
 <result pre="(2018). Epidemiological and clinical features of laboratory-diagnosed severe fever with" exact="thrombocytopenia" post="syndrome in China, 2011–17: a prospective observational study. Lancet"/>
 <result pre="L.et al.. (2019). Calcium channel blockers reduce severe fever with" exact="thrombocytopenia" post="syndrome virus (SFTSV) related fatality. Cell Res.29, 739–753. 10.1038/s41422-019-0214-z31444469"/>
 <result pre="among hospitalized patients in china who had severe fever with" exact="thrombocytopenia" post="syndrome. Clin. Infect. Dis.57, 1292–1299. 10.1093/cid/cit53023965284 LiuY.WuB.PaesslerS.WalkerD. H.TeshR. B.YuX."/>
 <result pre="H.TeshR. B.YuX. J. (2014). The pathogenesis of severe fever with" exact="thrombocytopenia" post="syndrome virus infection in alpha/beta interferon knockout mice: insights"/>
 <result pre="adverse events associated with ribavirin therapy for Severe fever with" exact="thrombocytopenia" post="syndrome. Antiviral Res.119, 19–22. 10.1016/j.antiviral.2015.04.00625892251 MendozaE. J.RacineT.KobingerG. P. (2017)."/>
 <result pre="(2011). Guideline for prevention and treatment of severe fever with" exact="thrombocytopenia" post="syndrome (2010 version). Chinese J. Clin. Infect. Dis.4, 193−194."/>
 <result pre="version). Chinese J. Clin. Infect. Dis.4, 193−194. NachbagauerR.KrammerF. (2017). Universal" exact="influenza" post="virus vaccines and therapeutic antibodies. Clin. Microbiol. Infect.23, 222–228."/>
 <result pre="10.1016/j.cmi.2017.02.00928216325 NakamuraS.AzumaM.MaruhashiT.SogabeK.SumitaniR.UemuraM.et al.. (2018). Steroid pulse therapy in patients with" exact="encephalopathy" post="associated with severe fever with thrombocytopenia syndrome. J. Infect."/>
 <result pre="therapy in patients with encephalopathy associated with severe fever with" exact="thrombocytopenia" post="syndrome. J. Infect. Chemother.24, 389–392. 10.1016/j.jiac.2017.11.00429428565 NingY.MoQ.FengK.MinY. Q.LiM.HouD.et al.."/>
 <result pre="STAT1. Front. Immunol.10:1182. 10.3389/fimmu.2019.0118231191546 NiuG.LiJ.LiangM.JiangX.JiangM.YinH.et al.. (2013). Severe fever with" exact="thrombocytopenia" post="syndrome virus among domesticated animals, China. Emerg. Infect. Dis.19,"/>
 <result pre="a coffee-related organic acid, inhibits infection by severe fever with" exact="thrombocytopenia" post="syndrome virus in vitro. J. Infect. Chemother.24, 597–601. 10.1016/j.jiac.2018.03.00529628386"/>
 <result pre="Plasma exchange and ribavirin for rapidly progressive severe fever with" exact="thrombocytopenia" post="syndrome. Int. J. Infect. Dis.18, 84–86. 10.1016/j.ijid.2013.08.01124161209 RamuJ.KonakT.PauleM. G.HanigJ."/>
 <result pre="Neurotoxicology56, 225–232. 10.1016/j.neuro.2016.08.01127555423 SaijoM. (2018). Pathophysiology of severe fever with" exact="thrombocytopenia" post="syndrome and development of specific antiviral therapy. J. Infect."/>
 <result pre="effect of post-exposure treatment with antiserum on severe fever with" exact="thrombocytopenia" post="syndrome (SFTS) in a mouse model of SFTS virus"/>
 <result pre="Combination effects of ribavirin and interferons on severe fever with" exact="thrombocytopenia" post="syndrome virus infection. Virol. J.12:181. 10.1186/s12985-015-0412-326527529 ShimojimaM.FukushiS.TaniH.YoshikawaT.FukumaA.TaniguchiS.et al.. (2014)."/>
 <result pre="ShimojimaM.FukushiS.TaniH.YoshikawaT.FukumaA.TaniguchiS.et al.. (2014). Effects of ribavirin on severe fever with" exact="thrombocytopenia" post="syndrome virus in vitro. Jpn. J. Infect. Dis.67, 423–427."/>
 <result pre="The first identification and retrospective study of severe fever with" exact="thrombocytopenia" post="syndrome in Japan. J. Infect. Dis.209, 816–827. 10.1093/infdis/jit60324231186 TangH.YaoX.YaoC.ZhaoX.ZuoH.LiZ."/>
 <result pre="in Japan. J. Infect. Dis.209, 816–827. 10.1093/infdis/jit60324231186 TangH.YaoX.YaoC.ZhaoX.ZuoH.LiZ. (2017). Anti-colon" exact="cancer" post="effect of caffeic acid p-nitro-phenethyl ester in vitro and"/>
 <result pre="in the treatment of infections with lethal severe fever with" exact="thrombocytopenia" post="syndrome virus. mSphere1, e00061–e00015. 10.1128/mSphere.00061-1527303697 TaniH.KomenoT.FukumaA.FukushiS.TaniguchiS.ShimojimaM.et al.. (2018). Therapeutic"/>
 <result pre="al.. (2018). Therapeutic effects of favipiravir against severe fever with" exact="thrombocytopenia" post="syndrome virus infection in a lethal mouse model: dose-efficacy"/>
 <result pre="T. P.ManP. K. C.et al.. (2019). Endemic severe fever with" exact="thrombocytopenia" post="syndrome, Vietnam. Emerg. Infect. Dis.25, 1029–1031. 10.3201/eid2505.18146331002059 UtsunomiyaH.IchinoseM.IkedaK.UozakiM.MorishitaJ.KuwaharaT.et al.."/>
 <result pre="10.3201/eid2505.18146331002059 UtsunomiyaH.IchinoseM.IkedaK.UozakiM.MorishitaJ.KuwaharaT.et al.. (2014). Inhibition by caffeic acid of the" exact="influenza" post="a virus multiplication in vitro. Int. J. Mol. Med.34,"/>
 <result pre="al.. (2017). Screening of FDA-approved drugs for inhibitors of Japanese" exact="encephalitis" post="virus infection. J. Virol.91, e01055–e01017. 10.1128/JVI.01055-1728814523 WelchS. R.GuerreroL. W.ChakrabartiA."/>
 <result pre="of therapeutic plasma exchange in patients having severe fever with" exact="thrombocytopenia" post="syndrome. Korean J. Intern. Med.34, 902–909. 10.3904/kjim.2016.19429117665 YoshikawaR.SakabeS.UrataS.YasudaJ. (2019)."/>
 <result pre="902–909. 10.3904/kjim.2016.19429117665 YoshikawaR.SakabeS.UrataS.YasudaJ. (2019). Species-specific pathogenicity of severe fever with" exact="thrombocytopenia" post="syndrome virus is determined by anti-STAT2 activity of NSs."/>
 <result pre="YuX. J.LiangM. F.ZhangS. Y.LiuY.LiJ. D.SunY. L.et al.. (2011). Fever with" exact="thrombocytopenia" post="associated with a novel bunyavirus in China. N. Engl."/>
 <result pre="two-tier system identifies an entry inhibitor of severe fever with" exact="thrombocytopenia" post="syndrome virus. Viruses11:E385. 10.3390/v1104038531027241 ZhuL.YinF.MomingA.ZhangJ.WangB.GaoL.et al.. (2019). First case"/>
 <result pre="ZhuL.YinF.MomingA.ZhangJ.WangB.GaoL.et al.. (2019). First case of laboratory-confirmed severe fever with" exact="thrombocytopenia" post="syndrome disease revealed the risk of SFTSV infection in"/>
</results>
